LYVLISO
Live / Applied — Second extension granted (statement of use) (as of 12 Nov 2025)
What this means for you
Not registered yet, but its 29 Nov 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98290659
- Mark type
- Stylized text
- Filed
- 29 Nov 2023
- Published for opposition
- 06 Aug 2024
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment, management and prevention of neurological diseases and disorders, psychiatric diseases and disorders, central nervous system conditions, and brain disorders
Owner
- Neumora Therapeutics, Inc., Watertown, MA, US
- Neumora Therapeutics, Inc., Watertown, MA, US
Prosecution history
- 13 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Nov 2025 — SOU EXTENSION 2 GRANTED
- 12 Nov 2025 — SOU EXTENSION 2 FILED
- 12 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Jan 2025 — SOU EXTENSION 1 GRANTED
- 15 Jan 2025 — SOU EXTENSION 1 FILED
- 15 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Dec 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 03 Sept 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 06 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Aug 2024 — PUBLISHED FOR OPPOSITION
- 17 Jul 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jun 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER